John Boyce

Exosome Diagnostics has appointed John Boyce as its Chief Executive Officer. Boyce is a co-founder of GnuBio and served as president and CEO of the company until its acquisition by Bio-Rad, after which he headed the Bio-Rad Digital Biology Center. Prior to his work at GnuBio, Boyce served as head of business development and scientific collaborations at Helicos. He was also senior director of commercial development at Parallele Biosciences and senior director of sales and marketing at Sequenom.